HOVR · New Horizon Aircraft Ltd.

This 8-K filing centers on New Horizon Aircraft’s third-quarter fiscal 2026 operational and financial update, anchored in Exhibit 99.1 — a press release dated April 14, 2026. While no income statement metrics (e.g., revenue, net loss, EPS) are disclosed, the Company explicitly reports $20 million in cash as of February 28, 2026, and affirms this provides sufficient working capital to achieve key aircraft development milestones through fiscal 2027. This liquidity position is critical for an early-stage aerospace developer with no commercial revenue, directly addressing investor concerns about funding runway. Operationally, the quarter marked a strategic inflection point: the Cavorite X7 shifted from design into full-scale manufacturing, with assembly targeted for completion later in 2026 and first flight tests scheduled for early 2027. The establishment of tier-1 manufacturing partnerships — RAMPF for fuselage and North Aircraft Industries for wings and structural testing — signals credible supply chain build-out and mitigates execution risk. The collaboration with MHIRJ further strengthens engineering bandwidth. Notably, third-party validation of the Cavorite X7’s projected $0.97/ASM operating cost provides an early, externally assessed benchmark for economic viability — a rare and material data point in the pre-revenue eVTOL sector. CEO Brandon Robinson’s commentary underscores confidence in timeline adherence, reinforcing credibility around the 2026 assembly and 2027 flight test targets. Collectively, these disclosures advance de-risking across liquidity, manufacturing readiness, technical validation, and partner credibility — all essential for sustaining investor and regulatory confidence ahead of certification and commercialization.